Empagliflozin vs Enfortumab Vedotin

## Empagliflozin vs Enfortumab Vedotin: Overview

This comparison examines the pharmacological differences between **Empagliflozin** and **Enfortumab Vedotin**.

## Mechanism of Action

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

## Pharmacokinetics

**Half-life**: Empagliflozin — 12.4 hours; Enfortumab Vedotin — N/A.

## Chemical Properties

**Molecular Formula**: Empagliflozin — C23H27ClO7; Enfortumab Vedotin — N/A.

**Molecular Weight**: Empagliflozin — 450.9100 g/mol; Enfortumab Vedotin — N/A.

**Type**: Empagliflozin — Small molecule; Enfortumab Vedotin — Antibody drug conjugate.